A. Jones

No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected Subjects

A. Salem, G. Taylor, C. Klein, 2015, Antimicrobial Agents and Chemotherapy.

Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure–response analysis

A. Salem, K. Freise, S. Enschede, 2016, Cancer Chemotherapy and Pharmacology.

Relationship between venetoclax exposure, rituximab coadministration, and progression‐free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy

A. Salem, K. Freise, M. Verdugo, 2017, Hematological oncology.

Moving Beyond Maximum Tolerated Dose for Targeted Oncology Drugs: Use of Clinical Utility Index to Optimize Venetoclax Dosage in Multiple Myeloma Patients

A. Salem, A. Jones, R. Menon, 2017, Clinical pharmacology and therapeutics.

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

A. Salem, K. Freise, R. Humerickhouse, 2017, Clinical Pharmacokinetics.

Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis

A. Salem, K. Freise, R. Humerickhouse, 2016, The AAPS Journal.

Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.

V. Ivaturi, P. Orchard, Liusheng Huang, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

E. Ngaimisi, M. Gopalakrishnan, C. Laffont, 2020, Clinical Pharmacokinetics.

Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure‐Response Analyses Underutilized?

Aksana K. Jones, Ahmed Hamed Salem, Kevin J. Freise, 2019, CPT: pharmacometrics & systems pharmacology.

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts

A. Diacon, Yongge Liu, K. Romero, 2022, BMC Infectious Diseases.

Abstracts accepted for American Conference on Pharmacometrics 2016 (ACoP7)

John L. Johnson, A. Diacon, S. Dutta, 2016, Journal of Pharmacokinetics and Pharmacodynamics.

Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis

A. Salem, K. Freise, R. Humerickhouse, 2016, The AAPS Journal.